the global emergence of Helicobacter pylori antibiotic resistance

I Thung, H Aramin, V Vavinskaya… - Alimentary …, 2016 - Wiley Online Library
Background Helicobacter pylori is one of the most prevalent global pathogens and can lead
to gastrointestinal disease including peptic ulcers, gastric marginal zone lymphoma and …

[HTML][HTML] Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment

TL Testerman, J Morris - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) is an extremely common, yet underappreciated, pathogen that
is able to alter host physiology and subvert the host immune response, allowing it to persist …

[HTML][HTML] Review of current diagnostic methods and advances in Helicobacter pylori diagnostics in the era of next generation sequencing

D Pohl, PM Keller, V Bordier… - World journal of …, 2019 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) infection is highly prevalent in the human population and may
lead to severe gastrointestinal pathology including gastric and duodenal ulcers, mucosa …

全国中西医整合治疗幽门螺杆菌相关“病-证” 共识

胡伏莲, 张声生 - 中国中西医结合消化杂志, 2018 - whuhzzs.com
幽门螺杆菌(Helicobacterpylori) 与慢性胃炎, 消化性溃疡, 胃癌及胃黏膜相关淋巴组织(MALT)
淋巴瘤的发生发展密切相关. 1994 年幽门螺杆菌被世界卫生组织列为胃癌发生的I 类致癌因子 …

Helicobacter pylori biofilm formation and its potential role in pathogenesis

S Hathroubi, SL Servetas, I Windham… - Microbiology and …, 2018 - Am Soc Microbiol
Despite decades of effort, Helicobacter pylori infections remain difficult to treat. Over half of
the world's population is infected by H. pylori, which is a major cause of duodenal and …

[HTML][HTML] Pathogenesis and clinical management of Helicobacter pylori gastric infection

BB de Brito, FAF da Silva, AS Soares… - World journal of …, 2019 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) is a gram-negative bacterium that infects approximately 4.4
billion individuals worldwide. However, its prevalence varies among different geographic …

[HTML][HTML] Treatment of Helicobacter pylori infection: Current and future insights

M Safavi, R Sabourian, A Foroumadi - World journal of clinical …, 2016 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) is an important major cause of peptic ulcer disease and gastric
malignancies such as mucosa-associated lymphoid tissue lymphoma and gastric …

Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events

LV McFarland, Y Huang, L Wang… - United European …, 2016 - journals.sagepub.com
Background Eradication rates with triple therapy for Helicobacter pylori infections have
currently declined to unacceptable levels worldwide. Newer quadruple therapies are …

[HTML][HTML] Reducing anastomotic leak in colorectal surgery: The old dogmas and the new challenges

J Meyer, S Naiken, N Christou, E Liot… - World journal of …, 2019 - ncbi.nlm.nih.gov
Anastomotic leak (AL) constitutes a significant issue in colorectal surgery, and its incidence
has remained stable over the last years. The use of intra-abdominal drain or the use of …

[HTML][HTML] Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance

SM Smith, C O'Morain, D McNamara - World journal of …, 2014 - ncbi.nlm.nih.gov
The gram-negative bacterium Helicobacter pylori (H. pylori) causes chronic gastritis, gastric
and duodenal ulcers, gastric cancer and mucosa-associated lymphoid tissue lymphoma …